← Open Payments lookup

KACY CLINKENBEARD: Open Payments

NPI 1417579269 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,438 in 133 payments from 20 companies in 2025. Trend: 2023 $1,223 · 2024 $1,924 · 2025 $2,438

Food & beverage: $2,323Education: $114
CompanyPaymentsAmount
ABBVIE INC.35$630
Janssen Biotech, Inc.16$469
Salix Pharmaceuticals, a division of Bausch Health US, LLC27$300
Takeda Pharmaceuticals U.S.A., Inc.8$182
GENZYME CORPORATION9$175
Gilead Sciences, Inc.6$139
Phathom Pharmaceuticals, Inc.10$130
Ardelyx, Inc.4$87
Regeneron Healthcare Solutions, Inc.2$52
Sandoz Inc.2$47

Products named: TREMFYA, RINVOQ, XIFAXAN, DUPIXENT, ENTYVIO, LINZESS, VOQUEZNA, CREON.

Industry payments across SC — which companies pay providers there.